Literature DB >> 10214974

Effects of diabetes on tissue content and evoked release of calcitonin gene-related peptide-like immunoreactivity from rat sensory nerves.

N A Calcutt1, P Chen, X Y Hua.   

Abstract

We measured the evoked release of calcitonin gene-related peptide-like immunoreactivity (CGRP-LI) from sensory nerve terminals in tracheas from control and diabetic rats using an in vitro perfusion system and also the CGRP-LI content of the vagus nerve and trachea. Diabetes caused a 29% (P < 0.05) reduction in CGRP-LI content of the vagus nerve and a decrease in CGRP-LI release from nerve endings in the trachea evoked by either capsaicin (30% decrease, P < 0.05) or electrical field stimulation (50% decrease: P < 0.05). In contrast, there was a 50% increase in the CGRP-LI content of the unstimulated trachea. Thus, diabetes induces an impairment in neuropeptide release from peripheral terminals of sensory nerves that corresponds to decreased levels in the supplying nerve but is not reflected in tissue measurements that incorporate nerve terminals. Impaired neuropeptide release may contribute to peripheral and central sensory dysfunction in diabetic rats.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10214974     DOI: 10.1016/s0304-3940(98)00692-2

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  8 in total

1.  Topical Delivery of Muscarinic Receptor Antagonists Prevents and Reverses Peripheral Neuropathy in Female Diabetic Mice.

Authors:  Corinne G Jolivalt; Katie E Frizzi; May Madi Han; Andre J Mota; Lucie S Guernsey; Lakshmi P Kotra; Paul Fernyhough; Nigel A Calcutt
Journal:  J Pharmacol Exp Ther       Date:  2020-04-23       Impact factor: 4.030

2.  Painful diabetic neuropathy leads to functional CaV3.2 expression and spontaneous activity in skin nociceptors of mice.

Authors:  Tal Hoffmann; Katrin Kistner; Sonja L J Joksimovic; Slobodan M Todorovic; Peter W Reeh; Susanne K Sauer
Journal:  Exp Neurol       Date:  2021-08-25       Impact factor: 5.330

3.  Prevention of sensory disorders in diabetic Sprague-Dawley rats by aldose reductase inhibition or treatment with ciliary neurotrophic factor.

Authors:  N A Calcutt; J D Freshwater; A P Mizisin
Journal:  Diabetologia       Date:  2004-04       Impact factor: 10.122

4.  Functional magnetic resonance imaging of the spinal cord during sensory stimulation in diabetic rats.

Authors:  Krisztina L Malisza; Cheryl Jones; Marco L H Gruwel; Derek Foreman; Paul Fernyhough; Nigel A Calcutt
Journal:  J Magn Reson Imaging       Date:  2009-08       Impact factor: 4.813

Review 5.  Diabetic neuropathy: mechanisms to management.

Authors:  James L Edwards; Andrea M Vincent; Hsinlin T Cheng; Eva L Feldman
Journal:  Pharmacol Ther       Date:  2008-06-13       Impact factor: 12.310

6.  Concurrent activation of the somatosensory forebrain and deactivation of periaqueductal gray associated with diabetes-induced neuropathic pain.

Authors:  Pamela E Paulson; John W Wiley; Thomas J Morrow
Journal:  Exp Neurol       Date:  2007-09-12       Impact factor: 5.330

7.  Nanoscale pathogens treated with nanomaterial-like peptides: a platform technology appropriate for future pandemics.

Authors:  Alaa F Nahhas; Alrayan F Nahhas; Thomas J Webster
Journal:  Nanomedicine (Lond)       Date:  2021-05-14       Impact factor: 5.307

Review 8.  Lost in Translation? Measuring Diabetic Neuropathy in Humans and Animals.

Authors:  Heung Yong Jin; Seong-Su Moon; Nigel A Calcutt
Journal:  Diabetes Metab J       Date:  2020-12-15       Impact factor: 5.376

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.